SCOPUS 정보 검색 플랫폼

Volumn 96, Issue 10, 2005, Pages 1365-1369

Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease

(7) Mason, Peter J a Chakrabarti, Subrata b Albers, Anne A b Rex, Sybille b Vitseva, Olga b Varghese, Sonia b Freedman, Jane E b

a BRIGHAM AND WOMEN S HOSPITAL (United States)

b BOSTON UNIVERSITY SCHOOL OF MEDICINE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CD40 LIGAND; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; WARFARIN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SURFACE PROPERTY; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOOD PRESSURE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CD40 LIGAND; CORONARY ARTERIOSCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET COUNT; PLATELET FUNCTION TESTS; THROMBOXANE B2;

EID: 27644529731 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/j.amjcard.2005.07.039 Document Type: Article

Times cited : (40)

References (9)

1
- 0036130828
- CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism
- P. Andre, K.S. Prasad, C.V. Denis, M. He, J.M. Papalia, R.O. Hynes, D.R. Phillips, D.D. Wagner CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism Nat Med 8 2002 247 252
- (2002) Nat Med , vol.8 , pp. 247-252
- Andre, P.¹ Prasad, K.S.² Denis, C.V.³ He, M.⁴ Papalia, J.M.⁵ Hynes, R.O.⁶ Phillips, D.R.⁷ Wagner, D.D.⁸

2
- 0142055947
- New markers of inflammation and endothelial cell activation, part I
- P.E. Szmitko, C.H. Wang, R.D. Weisel, J.R. de Almeida, T.J. Anderson, S. Verma New markers of inflammation and endothelial cell activation, part I Circulation 108 2003 1917 1923
- (2003) Circulation , vol.108 , pp. 1917-1923
- Szmitko, P.E.¹ Wang, C.H.² Weisel, R.D.³ De Almeida, J.R.⁴ Anderson, T.J.⁵ Verma, S.⁶

3
- 4043055748
- Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk
- E.R. Ahn, G. Lander, W. Jy, C.J. Bidot, J.J. Jimenez, L.L. Horstman, Y.S. Ahn Differences of soluble CD40L in sera and plasma implications on CD40L assay as a marker of thrombotic risk Thromb Res 114 2004 143 148
- (2004) Thromb Res , vol.114 , pp. 143-148
- Ahn, E.R.¹ Lander, G.² Jy, W.³ Bidot, C.J.⁴ Jimenez, J.J.⁵ Horstman, L.L.⁶ Ahn, Y.S.⁷

4
- 12444253906
- Should soluble CD40 ligand be measured from serum or plasma samples?
- D. Bereczki, E. Nagy, A. Pal, M.T. Magyar, J. Balla Should soluble CD40 ligand be measured from serum or plasma samples? Arterioscler Thromb Vasc Biol 23 2003 1129 1130
- (2003) Arterioscler Thromb Vasc Biol , vol.23 , pp. 1129-1130
- Bereczki, D.¹ Nagy, E.² Pal, A.³ Magyar, M.T.⁴ Balla, J.⁵

5
- 13244250988
- Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma
- J. Thom, G. Gilmore, Q. Yi, G.J. Hankey, J.W. Eikelboom Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma (letter to the editor) J Thromb Haemost 2 2004 2067 2069
- (2004) J Thromb Haemost , vol.2 , pp. 2067-2069
- Thom, J.¹ Gilmore, G.² Yi, Q.³ Hankey, G.J.⁴ Eikelboom, J.W.⁵

6
- 0030853312
- Nitric oxide released from activated platelets inhibits platelet recruitment
- J.E. Freedman, J. Loscalzo, M.R. Bernard, C. Alpert, J.F. Keaney, A.D. Michelson Nitric oxide released from activated platelets inhibits platelet recruitment J Clin Invest 100 1997 350 356
- (1997) J Clin Invest , vol.100 , pp. 350-356
- Freedman, J.E.¹ Loscalzo, J.² Bernard, M.R.³ Alpert, C.⁴ Keaney, J.F.⁵ Michelson, A.D.⁶

7
- 0035183844
- Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets
- C.D. Garlichs, S. Eskafi, D. Raaz, A. Schmidt, J. Ludwig, M. Hermann, L. Klinghammer, W.G. Daniel, A. Schmeisser Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets Heart 86 2001 649 655
- (2001) Heart , vol.86 , pp. 649-655
- Garlichs, C.D.¹ Eskafi, S.² Raaz, D.³ Schmidt, A.⁴ Ludwig, J.⁵ Hermann, M.⁶ Klinghammer, L.⁷ Daniel, W.G.⁸ Schmeisser, A.⁹

8
- 0036529828
- Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis
- J.F. Viallard, A. Solanilla, B. Gauthier, C. Contin, J. Dechanet, C. Grosset, J.F. Moreau, V. Praloran, P. Nurden, J.L. Pellegrin Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis Blood 99 2002 2612 2614
- (2002) Blood , vol.99 , pp. 2612-2614
- Viallard, J.F.¹ Solanilla, A.² Gauthier, B.³ Contin, C.⁴ Dechanet, J.⁵ Grosset, C.⁶ Moreau, J.F.⁷ Praloran, V.⁸ Nurden, P.⁹ Pellegrin, J.L.¹⁰

9
- 2942546273
- Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization
- M.I. Furman, L.A. Krueger, M.D. Linden, M.R. Barnard, A.L. Frelinger, A.D. Michelson Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization J Am Coll Cardiol 43 2004 2319 2325
- (2004) J Am Coll Cardiol , vol.43 , pp. 2319-2325
- Furman, M.I.¹ Krueger, L.A.² Linden, M.D.³ Barnard, M.R.⁴ Frelinger, A.L.⁵ Michelson, A.D.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.